Results 61 to 70 of about 9,470 (201)

Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase

open access: yes, 2017
The topical application of minoxidil may achieve millimolar concentrations in the skin. We investigated whether millimolar minoxidil could induce vascular endothelial growth factor (VEGF), a possible effector for minoxidil-mediated hair growth, and how ...
Dohoon Kim   +10 more
core   +1 more source

EFECTIVITY MINOXIDIL AS A TREATMENT OF ALOPECIA AREATA

open access: yese-Jurnal Medika Udayana, 2014
Alopecia areata is hair loss with patchy formation, the most common cause of alopecia nonscarring. Occurred in 1,7 % of Americans aged 50 years. Canoccurs in both sexes, all races and any age.
Wayan Evie Frida Yustin
doaj  

Understanding Exosomes in Hair Regeneration

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Alopecia is a prevalent condition correlated with significant psychosocial challenges, while contemporary treatments exhibit variable efficacy, require extended use, and may cause adverse effects. This review aimed to comprehensively assess exosome‐mediated interventions as a novel cell‐free regenerative approach for hair ...
Paras Ahmad   +3 more
wiley   +1 more source

Minoxidil Stimulates Mouse Vibrissae Follicles in Organ Culture

open access: yes, 1989
Minoxidil, a potent vasodilator, stimulates the growth of terminal hair from vellus or miniaturized follicles in balding scalp. To study minoxidil's action on isolated follicles we developed and validated an organ culture system using mouse whisker ...
Buhl, Allen E.   +3 more
core   +1 more source

Unstable angina: A rare presentation of minoxidil intoxication: A case report and literature review

open access: yesJournal of Research in Pharmacy Practice, 2018
Minoxidil is an antihypertensive direct vasodilator that can cause severe toxicity when sufficiently ingested. We report a case of accidental ingestion of 5 ml topical minoxidil solution 5% presented with chest pain and new-onset ST depressions.
Farzad Gheshlaghi   +2 more
doaj   +1 more source

How to optimise tournament draws: The case of the FIFA World Cup

open access: yesInternational Transactions in Operational Research, Volume 34, Issue 2, Page 791-821, March 2027.
Abstract The organisers of major sports competitions use different policies with respect to constraints in the group draw. Our paper aims to rationalise these choices by analysing the trade‐off between attractiveness (the number of games played by teams from the same geographic zone) and fairness (the departure of the draw mechanism from a uniform ...
László Csató
wiley   +1 more source

Minoxidil: Inhibition of Proliferation of Keratinocytes In Vitro [PDF]

open access: yes, 1991
Previous studies have suggested that minoxidil stimulates growth of keratinocytes, possibly in a manner similar to the action of epidermal growth factor.
O'Keefe, Edward, Payne, Richard
core   +1 more source

The additive value of platelet-rich plasma to topical Minoxidil in the treatment of androgenetic alopecia: A systematic review and meta-analysis.

open access: yesPLoS ONE
ObjectiveIt still needs to be determined if platelet-rich plasma (PRP) has any added advantage over Minoxidil in treating androgenetic alopecia. We reviewed randomized controlled trials (RCTs) comparing scalp injections of PRP plus Minoxidil vs Minoxidil
Jia Yao   +5 more
doaj   +1 more source

Single‐Cell Profiling Reveals a Protective WNT5A‐ATF3‐FOSB Signaling Axis in Hair Follicle Stem Cells During Androgenetic Alopecia

open access: yesAdvanced Science, Volume 13, Issue 61, 3 November 2026.
Androgenetic alopecia (AGA) is a common form of hair loss with limited treatment options. Silencing of WNT5A signaling, which is widely known as the trigger of the ncWNT signaling pathway, happens in hair follicle stem cells from balding areas. It leads to downregulation of ATF3 and its target FOSB.
Ruiyu Luo   +10 more
wiley   +1 more source

Fatal Toxic Epidermal Necrolysis Associated with Minoxidil

open access: yes, 2009
Minoxidil is a direct-acting peripheral vasodilator for the treatment of symptomatic hypertension, or refractory hypertension associated with target organ damage, that is not manageable with a diuretic and two other antihypertensive drugs.
Chahine-Chakhtoura, Corinne   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy